about
A core extended naphtalene diimide G-quadruplex ligand potently inhibits herpes simplex virus 1 replicationDrug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replicationNon-axial view of the varicella-zoster virus portal protein reveals conserved crown, wing and clip architecture.Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseControlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture.Acyclovir Lauriad(®): a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis.Helicase-primase as a target of new therapies for herpes simplex virus infections.Visualization of DNA G-quadruplexes in herpes simplex virus 1-infected cells.A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.Lip ulceration in an immunocompromised patient.Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USAThe interaction of HSV-1 tegument proteins pUL36 and pUL37: a novel target for antivirals that inhibit viral assemblyVolatile Acid-Solvent Evaporation (VASE): Molecularly Homogeneous Distribution of Acyclovir in a Bioerodable Polymer Matrix for Long-Term Treatment of Herpes Simplex Virus-1 InfectionsExperimental Dissection of the Lytic Replication Cycles of Herpes Simplex Viruses
P2860
Q30250926-33A3EB72-DB1D-401A-8BBE-B8BCC105E457Q34464333-A33A2892-3E0F-4B80-8DE6-CDF260A8A623Q34597590-242DCA96-BAC4-4C1C-90BC-14367DB33967Q35770254-00353756-E1E4-4C6D-B429-E879EA4AAFBFQ36730096-A5B2B477-DB13-4745-998C-3DE971D5C01AQ37523020-5A5DD1A1-C7A3-48C9-A9C7-9B89E45AA255Q37612784-2304287F-5BFD-46E4-A043-0E84B5A1A2E7Q38181219-65D5D7C6-4317-410E-930D-84112091B4C0Q38351481-D074D32B-349A-4B86-B206-AF979056A5B0Q38735386-83E6BF23-1076-42D4-AC72-FEC63FD089E3Q39010658-CEEECE5F-13F1-4ED8-8668-80A06B298382Q52661535-3C00F4C6-2890-435B-A04C-D08C84DAF821Q56000877-A71F9B45-74E5-41B4-8542-1D4EB695CC9EQ57076505-6D81B544-7305-4CFB-AED1-480D9BA67243Q57821292-4CA289EA-0DD9-48B5-8FC4-A98E97EB4770Q58572935-C4390DBD-F0C9-46C2-9FF0-49098AF7CC78
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antiviral agents for herpes simplex virus.
@ast
Antiviral agents for herpes simplex virus.
@en
Antiviral agents for herpes simplex virus.
@nl
type
label
Antiviral agents for herpes simplex virus.
@ast
Antiviral agents for herpes simplex virus.
@en
Antiviral agents for herpes simplex virus.
@nl
prefLabel
Antiviral agents for herpes simplex virus.
@ast
Antiviral agents for herpes simplex virus.
@en
Antiviral agents for herpes simplex virus.
@nl
P1476
Antiviral agents for herpes simplex virus.
@en
P2093
Hugh J Field
R Anthony Vere Hodge
P356
10.1016/B978-0-12-405880-4.00001-9
P577
2013-01-01T00:00:00Z